Results 11 to 20 of about 8,977,908 (300)

Epidemiological Characteristics of Meningococcal Infection in Moscow

Эпидемиология и вакцинопрофилактика, 2020
Aims. The purpose of this study was to identify current epidemiological features of meningococcal infection in Moscow.Materials and methods. Cases of invasive meningococcal disease in Moscow from 2014 to 2018 and the biomaterial from patients with an ...
M. I. Gritsay, M. A. Koroleva, N. N. Fomkina, I. S. Koroleva   +3 more
doaj   +1 more source

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India

Human Vaccines & Immunotherapeutics, 2022
Meningococcal disease is highly transmissible, life-threatening and leaves significant sequelae in survivors. Every year, India, which has a plethora of risk factors for meningococcal disease, reports around 3000 endemic cases.
Anand P. Dubey, Rashna Dass Hazarika, Veronique Abitbol, Shafi Kolhapure, Someya Agrawal   +4 more
doaj   +1 more source

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease

BMC Research Notes, 2020
Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
M. Taha, A. Deghmane
semanticscholar   +1 more source

Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease

Canada Communicable Disease Report, 2020
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison, Robert Stirling, Oliver Baclic, Wendy Vaudry   +3 more
doaj   +1 more source

Meningococcal disease in one soldier patient: case report from Vietnam

Vietnam Journal of Science, Technology and Engineering, 2021
Meningococcal disease is caused by an infection with Neisseria meningitidis (N. meningitidis) bacteria, which is responsible for two major forms of the disease including meningitis and/or septicaemia. N.
Nguyen Thanh Viet, Nguyen Minh Nam, Nguyen Vu Trung, Do Tuan Anh, Hoang Van Tong   +4 more
doaj   +1 more source

Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal.

Journal of the American Medical Association (JAMA), 2020
Importance A 4-component meningococcus group B vaccine (4CMenB) is the only vaccine in use to prevent group B invasive meningococcal disease in young children, but no matched controlled studies have evaluated it.
F. Rodrigues, R. Marlow, M. J. Simões, L. Danon, S. Ladhani, A. Finn   +5 more
semanticscholar   +1 more source

The association of meningococcal disease with influenza in the United States, 1989-2009. [PDF]

PLoS ONE, 2014
Prior influenza infection is a risk factor for invasive meningococcal disease. Quantifying the fraction of meningococcal disease attributable to influenza could improve understanding of viral-bacterial interaction and indicate additional health benefits ...
Jessica Hartman Jacobs, Cécile Viboud, Eric Tchetgen Tchetgen, Joel Schwartz, Claudia Steiner, Lone Simonsen, Marc Lipsitch   +6 more
doaj   +1 more source

Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience

Archives of Disease in Childhood, 2020
Meningococcal disease remains one of the most feared infectious diseases worldwide because of its sudden onset, rapid progression and high case fatality rates, while survivors are often left with severe long-term sequelae. Young children have the highest
C. Isitt, C. Cosgrove, M. Ramsay, S. Ladhani   +3 more
semanticscholar   +1 more source

Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.

JAMA pediatrics, 2020
Importance In 2005, the US Advisory Committee on Immunization Practices recommended routine quadrivalent meningococcal conjugate (MenACWY) vaccine for all adolescents aged 11 to 12 years, and in 2010, a booster dose for adolescents aged 16 years ...
Sarah A Mbaeyi, Tracy Pondo, Amy E. Blain, D. Yankey, Caelin C. Potts, A. Cohn, S. Hariri, N. Shang, Jessica R Macneil   +8 more
semanticscholar   +1 more source

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study

The Lancet Public Health, 2017
Background: Since 2009, the incidence of meningococcal serogroup W disease has increased rapidly in the UK because of a single strain (the so-called original UK strain) belonging to the hypervirulent sequence type-11 clonal complex (cc11), with a variant
Dr Mirjam J Knol, PhD, Susan J M Hahné, PhD, Jay Lucidarme, PhD, Helen Campbell, MSc, Hester E de Melker, PhD, Stephen J Gray, PhD, Prof Ray Borrow, FRCPath, Shamez N Ladhani, MRCPCH, Mary E Ramsay, FFPHM, Arie van der Ende, PhD   +9 more
doaj   +1 more source